Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$267.19+0.00 (+0.00%)
Delayed quote: Sep 9, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 4:00 PM EDT
The latest quarterly EBT is $6.75 Billion with a quarter-over-quarter change of +12.64%. Earnings Before Tax (EBT), also called pre-tax income, represents a company's profit after all operating and non-operating expenses but before income tax expense.
Reported quarterly EBT; no daily interpolation.
$6.75B
$6.75 Billion
+12.64%
vs. $5.99B prior quarter
96
Quarters of data available
| Period | EBT | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $6.75B | +$757.00M | +12.64% |
| Quarter ended Mar 2026 | $5.99B | +$1.02B | +20.62% |
| Quarter ended Dec 2025 | $4.97B | −$2.53B | -33.72% |
| Quarter ended Sep 2025 | $7.49B | +$1.00B | +15.44% |
| Quarter ended Jun 2025 | $6.49B | −$7.14B | -52.38% |
| Quarter ended Mar 2025 | $13.63B | +$9.74B | +250.68% |
| Quarter ended Dec 2024 | $3.89B | +$549.00M | +16.45% |
| Quarter ended Sep 2024 | $3.34B | −$2.41B | -41.93% |
| Quarter ended Jun 2024 | $5.75B | +$2.03B | +54.77% |
| Quarter ended Mar 2024 | $3.71B | −$1.11B | -23.04% |
| Quarter ended Dec 2023 | $4.83B | −$391.00M | -7.49% |
| Quarter ended Oct 2023 | $5.22B | −$1.09B | -17.27% |
| Quarter ended Jul 2023 | $6.31B | +$7.59B | +589.98% |
| Quarter ended Apr 2023 | −$1.29B | −$5.49B | -130.64% |
| Quarter ended Dec 2022 | $4.20B | −$971.00M | -18.77% |
| Quarter ended Oct 2022 | $5.17B | −$668.00M | -11.44% |
| Quarter ended Jul 2022 | $5.84B | −$22.00M | -0.38% |
| Quarter ended Apr 2022 | $5.86B | +$1.03B | +21.22% |
| Quarter ended Dec 2021 | $4.84B | +$987.00M | +25.64% |
| Quarter ended Oct 2021 | $3.85B | −$2.81B | -42.22% |
| Quarter ended Jul 2021 | $6.66B | −$767.00M | -10.32% |
| Quarter ended Apr 2021 | $7.43B | +$5.78B | +351.06% |
| Quarter ended Dec 2020 | $1.65B | −$2.75B | -62.58% |
| Quarter ended Sep 2020 | $4.40B | +$461.00M | +11.70% |
| Quarter ended Jun 2020 | $3.94B | −$2.57B | -39.47% |
| Quarter ended Mar 2020 | $6.51B | +$2.29B | +54.31% |
| Quarter ended Dec 2019 | $4.22B | +$2.57B | +156.10% |
| Quarter ended Sep 2019 | $1.65B | −$5.39B | -76.61% |
| Quarter ended Jun 2019 | $7.04B | +$2.62B | +59.23% |
| Quarter ended Mar 2019 | $4.42B | +$1.30B | +41.64% |
| Quarter ended Dec 2018 | $3.12B | −$1.30B | -29.41% |
| Quarter ended Sep 2018 | $4.42B | −$550.00M | -11.06% |
| Quarter ended Jul 2018 | $4.97B | −$508.00M | -9.27% |
| Quarter ended Apr 2018 | $5.48B | +$2.92B | +114.10% |
| Quarter ended Dec 2017 | $2.56B | −$2.23B | -46.56% |
| Quarter ended Oct 2017 | $4.79B | +$42.00M | +0.88% |
| Quarter ended Jul 2017 | $4.75B | −$827.00M | -14.83% |
| Quarter ended Apr 2017 | $5.58B | +$1.25B | +28.93% |
| Quarter ended Dec 2016 | $4.32B | −$957.00M | -18.12% |
| Quarter ended Oct 2016 | $5.28B | +$377.00M | +7.69% |
| Quarter ended Jul 2016 | $4.90B | −$390.00M | -7.37% |
| Quarter ended Apr 2016 | $5.29B | +$1.54B | +40.87% |
| Quarter ended Dec 2015 | $3.76B | −$364.00M | -8.83% |
| Quarter ended Sep 2015 | $4.12B | −$1.62B | -28.20% |
| Quarter ended Jun 2015 | $5.74B | +$166.00M | +2.98% |
| Quarter ended Mar 2015 | $5.58B | +$2.87B | +106.25% |
| Quarter ended Dec 2014 | $2.70B | −$4.11B | -60.31% |
| Quarter ended Sep 2014 | $6.81B | +$1.18B | +21.05% |
| Quarter ended Jun 2014 | $5.63B | +$202.00M | +3.72% |
| Quarter ended Mar 2014 | $5.42B | +$2.67B | +97.24% |
| Quarter ended Dec 2013 | $2.75B | −$917.00M | -25.01% |
| Quarter ended Sep 2013 | $3.67B | −$1.13B | -23.49% |
| Quarter ended Jun 2013 | $4.79B | +$532.00M | +12.49% |
| Quarter ended Mar 2013 | $4.26B | +$1.16B | +37.45% |
| Quarter ended Dec 2012 | $3.10B | −$495.00M | -13.77% |
| Quarter ended Sep 2012 | $3.60B | +$1.56B | +76.66% |
| Quarter ended Jul 2012 | $2.04B | −$3.01B | -59.66% |
| Quarter ended Apr 2012 | $5.04B | +$4.73B | +1486.48% |
| Quarter ended Dec 2011 | $318.00M | −$3.79B | -92.26% |
| Quarter ended Oct 2011 | $4.11B | +$689.00M | +20.13% |
| Quarter ended Jul 2011 | $3.42B | −$1.09B | -24.12% |
| Quarter ended Apr 2011 | $4.51B | +$2.28B | +102.42% |
| Quarter ended Dec 2010 | $2.23B | −$1.99B | -47.19% |
| Quarter ended Oct 2010 | $4.22B | −$1.00M | -0.02% |
| Quarter ended Jul 2010 | $4.22B | −$2.06B | -32.80% |
| Quarter ended Apr 2010 | $6.28B | +$3.68B | +141.17% |
| Quarter ended Dec 2009 | $2.60B | −$1.64B | -38.66% |
| Quarter ended Sep 2009 | $4.25B | −$18.00M | -0.42% |
| Quarter ended Jun 2009 | $4.26B | −$380.00M | -8.18% |
| Quarter ended Mar 2009 | $4.64B | +$1.13B | +32.02% |
| Quarter ended Dec 2008 | $3.52B | −$773.00M | -18.02% |
| Quarter ended Sep 2008 | $4.29B | −$85.00M | -1.94% |
| Quarter ended Jun 2008 | $4.38B | −$372.00M | -7.84% |
| Quarter ended Mar 2008 | $4.75B | +$2.42B | +103.56% |
| Quarter ended Dec 2007 | $2.33B | −$936.00M | -28.64% |
| Quarter ended Sep 2007 | $3.27B | −$763.00M | -18.93% |
| Quarter ended Jul 2007 | $4.03B | +$379.00M | +10.38% |
| Quarter ended Apr 2007 | $3.65B | +$944.00M | +34.86% |
| Quarter ended Dec 2006 | $2.71B | −$953.00M | -26.03% |
| Quarter ended Oct 2006 | $3.66B | +$58.00M | +1.61% |
| Quarter ended Jul 2006 | $3.60B | −$1.01B | -21.93% |
| Quarter ended Apr 2006 | $4.62B | +$1.98B | +74.94% |
| Quarter ended Dec 2005 | $2.64B | −$782.00M | -22.87% |
| Quarter ended Oct 2005 | $3.42B | +$154.00M | +4.72% |
| Quarter ended Jul 2005 | $3.27B | −$661.00M | -16.83% |
| Quarter ended Apr 2005 | $3.93B | +$1.30B | +49.60% |
| Quarter ended Dec 2004 | $2.63B | −$649.00M | -19.82% |
| Quarter ended Sep 2004 | $3.27B | −$161.00M | -4.69% |
| Quarter ended Jun 2004 | $3.44B | −$69.00M | -1.97% |
| Quarter ended Mar 2004 | $3.50B | +$1.13B | +47.60% |
| Quarter ended Dec 2003 | $2.37B | −$575.00M | -19.50% |
| Quarter ended Sep 2003 | $2.95B | +$893.00M | +43.43% |
| Quarter ended Jun 2003 | $2.06B | −$873.00M | -29.81% |
| Quarter ended Mar 2003 | $2.93B | +$1.08B | +58.41% |
| Quarter ended Dec 2002 | $1.85B | −$544.00M | -22.73% |
| Quarter ended Sep 2002 | $2.39B | N/A | N/A |